|
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
|
20 April 2020 |
|
GSK and Vir Biotechnology enter collaboration to find coronavirus solutions
|
08 April 2020 |
|
First-of-its-kind global collaboration launched to develop transformative treatment regimens for tuberculosis
|
03 March 2020 |
|
Clover and GSK announce research collaboration to evaluate coronavirus (COVID-19) vaccine candidate with pandemic adjuvant system
|
24 February 2020 |
|
FDA approves GSK's Voltaren Arthritis Pain for over-the-counter use in the United States
|
20 February 2020 |
|
CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
|
05 February 2020 |
|
GSK completes transaction with Pfizer to form new world-leading Consumer Healthcare Joint Venture
|
06 August 2019 |
|
Nucala (mepolizumab) gains FDA approval for two new self-administration options
|
07 June 2019 |
|
GSK reaches agreement to acquire TESARO, an oncology focused biopharmaceutical company
|
05 December 2018 |
|
GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics
|
13 April 2018 |